Please use this identifier to cite or link to this item:
|Title:||Inhaled terbutaline attenuates hyperpnoea-induced bronchoconstriction and mast cell activation in athletes|
|Keywords:||Prostaglandin;Terbutaline;Eucapnic hyperpnoea;Mast cell|
|Citation:||RESPIROLOGY, 2015, 20 pp. 53 - 53 (1)|
|Abstract:||Anderson et al.1,2 proposed that β2-adrenoceptor agonists taken by inhalation were superior to tablets for inhibiting exercise-induced bronchoconstriction (EIB) because sufficiently high concentration of drug was delivered directly to the airway to prevent mediator release from mast cells. The aim of this study was to investigate the effect of a clinically recommended dose of β2-adrenoceptor agonist on mast cell activation in response to dry air hyperpnoea in athletes with EIB.|
|Appears in Collections:||Dept of Life Sciences Research Papers|
Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.